PharmaFluidics Accelerates Commercialization with Fresh Funding
PharmaFluidics has announced it has raised 7.3 million euros in its bid to expand commercialization of its novel micro-chip device.
PharmaFluidics has announced it has raised 7.3 million euros in its bid to expand commercialization of its novel micro-chip device.
The financing round saw fresh investment from holding company FPIMâSFPI, as well as family offices Heran (Annie Vereecken) and RMM (Rudi Mariën). Existing investors PMV, Qbic, Theodorus, Innovatuin Fund, and Volksvermogen also reaffirmed their commitments with fresh funding.
The new funds will be used to further develop the pillar array technology platform, to expand the µPAC product range, and to scale up production and global sales.
“This funding will significantly boost our capacity to support our growth,” said Johan Devenyns, Managing Director of PharmaFluidics.
The company started shipping µPAC columns in September 2017, and have since served proteomics laboratories, medical centres, and pharmaceutical companies across Europe, the USA, and parts of Asia.
For more information, please visit www.pharmafluidics.com
18 Scientists from the US and Canada Win Scialog Awards for Advancing Chemical Lab Automation
July 7th 2025Seven research teams from universities across the United States and Canada have been honored for their collaborative efforts that integrate automation and artificial intelligence (AI) to tackle fundamental scientific challenges.
Detection and Risk Assessment of Mycotoxins in Commercial Tortillas Using HPLC-Based Methods
July 4th 2025A joint study between Selçuk University (Konya, Turkey) and Hitit University (Corum, Turkey) determined the natural occurrence and concentrations of the mycotoxins ochratoxin A (OTA) and deoxynivalenol (DON) in commercially available tortillas in Turkey. Contamination levels were quantified using validated analytical methods based on high-performance liquid chromatography (HPLC) coupled with fluorescence or ultraviolet detectors (HPLC-FLD or HPLC–UV).
GC Analysis Reveals PCB Accumulation in Antarctic Penguins and Krill
July 3rd 2025Researchers from the University of Murcia (Murcia, Spain), the Carlos III Health Institute (Madrid, Spain), and the University of Siena (Siena, Italy) evaluated the concentration of polychlorinated biphenyls (PCBs) in chinstrap penguins and krill from Deception Island (South Shetland Islands, Antarctica) to provide additional data of the PCB presence in Antarctica. To this end, 34 samples of different tissues corresponding to four adult specimens and six chicks were analyzed with gas chromatography.
